Evaluation of Physiological and Psychological Factors Involved in Exercise Intolerance in Patients With β-TTD
Condition(s) studied
Investigational drug(s) / intervention(s)
Maximal incremental exercise test: Participants will perform a symptom-limited maximal incremental exercise test on a cycle ergometer.
Study summary
The goal of this clinical trial is to compare physical ability of patients with transfusion-dependent β-thalassemia to control subjects. The main question it aims to answer is:
is there a difference in power output at first lactate threshold between patients with transfusion-dependent β-thalassemia and control subjects during maximal incremental exercise test.
Participants will have to realise differents exams including measurement of body compposition, maximal incremental exercise test, vertical jump, vasoreactivity test, blood sampling, quality of life questionnaires and neuromuscular assessments.
Eligibility
Primary outcome measure(s)
- Power at the first lactate threshold (PSL1) collected during the maximal incremental exercise test, compared between the two groups — 7 days after a transfusion for patient
Participants perform a maximal incremental exercise test on a cycle ergometer. The protocol includes one-minute intervals, with increments and initial power varying according to the subject's age and gender. The exercise continues until the subject is unable to maintain the power imposed by the current level. A drop of blood sample is taken from the earlobe and immediately analyzed to measure blood lactate concentration and determine first lactate threshold.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| CH Métropole Savoie | Chambéry | France | Recruiting |
More Centre Hospitalier Metropole Savoie trials in France
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07207577 on ClinicalTrials.gov ↗ ← All trials in France